NK-1 receptor is involved in the decreased movement in a rat chronic acid reflux oesophagitis model

Neurogastroenterol Motil. 2010 May;22(5):579-84, e125. doi: 10.1111/j.1365-2982.2009.01450.x. Epub 2010 Jan 5.

Abstract

Background: We previously reported that rats with reflux oesophagitis (RE) show a decrease in voluntary movement, which could be used as a measure of chronic visceral symptoms. However, what mediates these symptoms is still unknown, and pain-related neuropeptides or their receptors in oesophageal mucosa are possibly related to the symptom generation of oesophagitis. In the present study, we investigated the role of NK-1 receptor (NK-1R) as a mediator of oesophagitis symptoms.

Methods: Chronic RE was surgically induced using rats. The degree or severity of oesophageal symptoms was evaluated by assessing voluntary movement, which was monitored using an infrared sensor system. The NK-1R antagonist, L-732,138, was administered and changes in voluntary movement were assessed. Ten days after surgery, the rats were killed to examine the oesophagus. NK-1R and tachykinin-1 mRNA were detected by real-time RT-PCR. NK-1R protein expression was examined by Western blotting.

Key results: Voluntary movement of the oesophagitis model rats was significantly lower than that of the sham-operated rats on day 10. The size of oesophageal mucosal erosion did not correlate with the amount of voluntary movement. The amount of NK-1R protein and mRNA in the oesophageal tissue was significantly higher at both the erosion and non-erosion sites. The amount of tachykinin-1 mRNA in oesophageal tissue at the non-erosion sites was significantly higher in oesophagitis rats. The voluntary movement of oesophagitis rats was significantly increased by the administration of L-732,138.

Conclusions & inferences: The NK-1R and related neuropeptides are possibly involved in the decrease in voluntary movement of RE.

MeSH terms

  • Animals
  • Blotting, Western
  • Disease Models, Animal
  • Esophagitis, Peptic / metabolism*
  • Esophagus / drug effects
  • Esophagus / metabolism*
  • Male
  • Motor Activity / drug effects
  • Motor Activity / physiology*
  • Movement / drug effects
  • Movement / physiology*
  • Neurokinin-1 Receptor Antagonists
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Neurokinin-1 / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tachykinins / metabolism
  • Tryptophan / analogs & derivatives
  • Tryptophan / pharmacology

Substances

  • Neurokinin-1 Receptor Antagonists
  • RNA, Messenger
  • Receptors, Neurokinin-1
  • Tachykinins
  • 3,5-bis(trifluoromethyl)benzyl N-acetyltryptophan
  • Tryptophan